Agios Pharmaceuticals reported $0 in Sales Revenues for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Acceleron Pharma XLRN:US $ 39M 35M
Alexion Pharmaceuticals ALXN:US $ 1444.6M 0.2M
Alnylam Pharmaceuticals ALNY:US $ 125.85M 21.89M
Amgen AMGN:US $ 6206M 45M
AstraZeneca AZN:LN 6578M 303M
Bayer BAYN:GR € 10054M 2791M
Biogen BIIB:US $ 3376.1M 305.5M
Biomarin Pharmaceutical BMRN:US $ 429.48M 72.58M
Bluebird Bio BLUE:US $ 198.89M 177.03M
Bristol Myers Squibb BMY:US $ 10129M 652M
Daiichi Sankyo 4568:JP Y 236947M 12186M
Eli Lilly And LLY:US $ 5499.4M 360.4M
Exelixis EXEL:US $ 259M 33M
Gilead Sciences GILD:US $ 5143M 405M
GlaxoSmithKline GSK:LN 7624M 1466M
Immunogen IMGN:US $ 18.19M 3.16M
JAZZ PHA JAZZ:US $ 600.89M 38.45M
Merk MRK:US $ 10872M 1185M
Novartis NVS:US $ 12538M 916M
Pfizer PFE:US $ 11801M 227M
Puma Biotechnology PBYI:US $ 70M 19M
Regeneron Pharmaceuticals REGN:US $ 1952M 123.8M
Sarepta Therapeutics SRPT:US $ 137M 24M
Seattle Genetics SGEN:US $ 1061.73M 783.73M
Vertex Pharmaceuticals VRTX:US $ 1524.48M 9.38M
YTE INCY:US $ 688.04M 119.54M